NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,964,000 | -34.8% | 139,503 | -38.4% | 0.02% | -35.1% |
| Q1 2019 | $7,615,000 | +6.8% | 226,642 | +4.5% | 0.04% | +2.8% |
| Q4 2018 | $7,129,000 | -47.5% | 216,881 | -2.6% | 0.04% | -45.5% |
| Q3 2018 | $13,577,000 | +49.0% | 222,714 | +19.3% | 0.07% | +53.5% |
| Q2 2018 | $9,115,000 | -50.2% | 186,663 | +8.5% | 0.04% | -52.7% |
| Q1 2018 | $18,285,000 | +91325.0% | 172,081 | +10303.9% | 0.09% | – |
| Q4 2016 | $20,000 | +42.9% | 1,654 | +97.6% | 0.00% | – |
| Q3 2016 | $14,000 | -26.3% | 837 | -36.0% | 0.00% | – |
| Q2 2016 | $19,000 | +18.8% | 1,308 | +10.5% | 0.00% | – |
| Q1 2016 | $16,000 | – | 1,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |